MedTrace Logo

Dose Escalation Study of Vinpocetine in Healthy Volunteers

NCT06635746 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-10-10

No results posted yet for this study

Summary

The objective of this study is to determine whether vinpocetine is safe when taken at higher doses.

Conditions

  • Fetal Alcohol Spectrum Disorders

Interventions

DRUG

Vinpocetine

Increasing doses of vinpocetine to assess tolerability.

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • Stanford University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2026-06-01
Completion
2026-06-01
FDA Drug
Yes

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06635746 on ClinicalTrials.gov